Clinical trials
Phase 3 Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
80 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 4 |
| 2002 | 3 |
| 2003 | 1 |
| 2004 | 4 |
| 2005 | 6 |
| 2006 | 3 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 6 |
| 2010 | 3 |
| 2012 | 3 |
| 2014 | 4 |
| 2015 | 4 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 5 |
| 2020 | 4 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 2 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 51 |
| Terminated | 11 |
| Unknown status | 8 |
| Recruiting | 7 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ontario Clinical Oncology Group (OCOG) | 4 |
| Blue Earth Diagnostics | 3 |
| Eisai Inc. | 3 |
| Assistance Publique - Hôpitaux de Paris | 2 |
| Brigham and Women's Hospital | 2 |
| Eli Lilly and Company | 2 |
| Fondazione EMN Italy Onlus | 2 |
| GlaxoSmithKline | 2 |
| Lyra Therapeutics | 2 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Disease | 80 |
| Prostatic Neoplasms | 6 |
| Lung Neoplasms | 5 |
| Neoplasms | 5 |
| Multiple Myeloma | 4 |
| Epilepsy | 3 |
| Nervous System Diseases | 3 |
| Amyloid Neuropathies, Familial | 2 |
| Amyloidosis | 2 |
| Anxiety Disorders | 2 |
Trials
Showing 76 to 80 of 80. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.